Therapeutic management of classic lichen planopilaris: A systematic review

Clinical, Cosmetic and Investigational Dermatology

Volumn 11, Issue , 2018, Pages 91-102

  Errichetti, Enzo ^a   Figini, Matteo ^a   Croatto, Margherita ^a   Stinco, Giuseppe ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Lichen planopilaris; Management; Therapy; Treatment

Indexed keywords

CONTROLLED STUDY; HUMAN; REVIEW; SYSTEMATIC REVIEW;

EID: 85046293882     PISSN: None     EISSN: 11787015     Source Type: Journal    
DOI: 10.2147/CCID.S137870     Document Type: Review

References (34)

1. Lyakhovitsky A, Amichai B, Sizopoulou C, Barzilai A. A case series of 46 patients with lichen planopilaris: demographics, clinical evaluation, and treatment experience. J Dermatolog Treat. 2015;26(3):275-279.
2. Assouly P, Reigagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg. 2009;28(1):3-10.
3. Rácz E, Gho C, Moorman PW, Noordhoek Hegt V, Neumann HA. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. J Eur Acad Dermatol Venereol. 2013;27(12):1461-1470.
4. Piguet V, Breathnach SM, Le Cleach L. Lichen planus and lichenoid disorders. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s Textbook of Dermatology. 9th ed. Oxford: Wiley- Blackwell; 2016:37.6-37.7.
5. Errichetti E, Stinco G. Dermoscopy in general dermatology: a practical overview. Dermatol Ther (Heidelb). 2016;6(4):471-507.
6. Porta M. A Dictionary of Epidemiology. 6th ed. New York: Oxford University Press; 2014.
7. Oxford Centre for Evidence-Based Medicine. The Oxford 2011 Levels of Evidence. Available from: http://www.cebm.net/index.aspx?o=5653. Accessed December 9, 2017.
8. Naeini FF, Saber M, Asilian A, Hosseini SM. Clinical efficacy and safety of methotrexate versus hydroxychloroquine in preventing lichen planopilaris progress: a randomized clinical trial. Int J Prev Med. 2017;8:37.
9. Donati A, Assouly P, Matard B, Jouanique C, Reygagne P. Clinical and photographic assessment of lichen planopilaris treatment efficacy. J Am Acad Dermatol. 2011;64(3):597-598.
10. Chiang C, Sah D, Cho BK, Ochoa BE, Price VH. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010;62(3):387-392.
11. Spencer LA, Hawryluk EB, English JC 3rd. Lichen planopilaris: retrospective study and stepwise therapeutic approach. Arch Dermatol. 2009;145(3):333-334.
12. Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992;27(6 Pt 1):935-942.
13. Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003;49(4):667-671.
14. Mirmirani P, Karnik P. Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. Arch Dermatol. 2009;145(12):1363-1366.
15. Chieregato C, Zini A, Barba A, Magnanini M, Rosina P. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol. 2003;42(5):342-345.
16. Horn RT Jr, Goette DK, Odom RB, Olson EG, Guill MA. Immunofluorescent findings and clinical overlap in two cases of follicular lichen planus. J Am Acad Dermatol. 1982;7(2):203-207.
17. Abbasi NR, Orlow SJ. Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis. Pediatr Dermatol. 2009;26(1):118.
18. Garcovich S, Manco S, Zampetti A, Amerio P, Garcovich A. Onset of lichen planopilaris during treatment with etanercept. Br J Dermatol. 2008;158(5):1161-1163.
19. Isaac M, McNeely MC. Dermatitis herpetiformis associated with lichen planopilaris. J Am Acad Dermatol. 1995;33(6):1050-1051.
20. Jayasekera PS, Walsh ML, Hurrell D, Parslew RA. Case report of lichen planopilaris occurring in a pediatric patient receiving a tumor necrosis factor α inhibitor and a review of the literature. Pediatr Dermatol. 2016;33(2):e143-e146.
21. Lane TK, Kamino H, Walters RF, Meehan S, Pomeranz MK. Lichen planopilaris and psoriasis. Dermatol Online J. 2008;14(10):4.
22. Rosina P, Chieregato C, Magnanini M, Barba A. Lichen planopilaris and autoimmune thyroiditis. J Eur Acad Dermatol Venereol. 2002;16(6):648-649.
23. Muñoz-Pérez MA, Camacho F. Lichen planopilaris and scleroderma en coup de sabre. J Eur Acad Dermatol Venereol. 2002;16(5):542-544.
24. Ferrara RJ, Byrd RC. Lichen planopilaris: (follicular lichen planus). Cutis. 1973;12:869-870.
25. Baibergenova A, Walsh S. Use of pioglitazone in patients with lichen planopilaris. J Cutan Med Surg. 2012;16(2):97-100.
26. Mesinkovska NA, Tellez A, Dawes D, Piliang M, Bergfeld W. The use of oral pioglitazone in the treatment of lichen planopilaris. J Am Acad Dermatol. 2015;72(2):355-356.
27. Spring P, Spanou Z, de Viragh PA. Lichen planopilaris treated by the peroxisome proliferator activated receptor-g agonist pioglitazone: lack of lasting improvement or cure in the majority of patients. J Am Acad Dermatol. 2013;69(5):830-832.
28. Cho BK, Sah D, Chwalek J, et al. Efficacy and safety of mycophenolate mofetil for lichen planopilaris. J Am Acad Dermatol. 2010;62(3):393-397.
29. Tursen U, Api H, Kaya T, Ikizoglu G. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol Online J. 2004;10(1):24.
30. Metin A, Calka O, Ugras S. Lichen planopilaris coexisting with erythema dyschromicum perstans. Br J Dermatol. 2001;145(3):522-523.
31. Almaani N, Liu L, Perez A, Robson A, Mellerio JE, McGrath JA. Epidermolysis bullosa pruriginosa in association with lichen planopilaris. Clin Exp Dermatol. 2009;34(8):e825-e828.
32. George SJ, Hsu S. Lichen planopilaris treated with thalidomide. J Am Acad Dermatol. 2001;45(6):965-966.
33. Jouanique C, Reygagne P, Bachelez H, Dubertret L. Thalidomide is ineffective in the treatment of lichen planopilaris. J Am Acad Dermatol. 2004;51(3):480-481.
34. Vavricka BP, Haug I, Eliades I, Trueb R. 308-nm excimer laser treatment of lichen planopilaris of the scalp. Dermatology. 2006;213:74.